Adverse Events: complete case · preventing C. difficile associated diarrhea
It is very uncertain whether probiotics changes adverse Events: complete case compared with control (very low certainty).
1 finding from 1 review
Incidence AAD: complete case · preventing C. difficile associated diarrhea
Probiotics may leads to lower incidence AAD: complete case compared with control (low certainty).
1 finding from 1 review
AAD (Adults) · preventing C. difficile associated diarrhea
Probiotics may leads to lower AAD (Adults) compared with control (low certainty).
1 finding from 1 review
AAD (Children) · preventing C. difficile associated diarrhea
Probiotics probably leads to lower AAD (Children) compared with control (moderate certainty).
1 finding from 1 review
Clinical response · Patients with collagenous colitis
It is very uncertain whether probiotics changes clinical response compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · Patients with collagenous colitis
It is very uncertain whether probiotics changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
It is very uncertain whether probiotics changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
Systemic inflammatory response syndrome · patients with acute pancreatitis
It is very uncertain whether probiotics changes systemic inflammatory response syndrome compared with control (very low certainty).
1 finding from 1 review
Organ failure · patients with acute pancreatitis
It is very uncertain whether probiotics changes organ failure compared with control (very low certainty).
1 finding from 1 review
Adverse events · patients with acute pancreatitis
Probiotics showed no clear difference in adverse events compared with control (low certainty).
1 finding from 1 review
Serious adverse events · patients with acute pancreatitis
It is very uncertain whether probiotics changes serious adverse events compared with control (very low certainty).
1 finding from 1 review
Frequency of defecation (mean number of bowel movements per week) · children with chronic constipation without a physical explanation
1 finding from 1 review
Global assessment of treatment success · children with chronic constipation without a physical explanation
Probiotics and osmotic laxative showed no clear difference in global improvement or treatment success, as defined by primary studies compared with osmotic laxative (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · children with chronic constipation without a physical explanation
It is very uncertain whether probiotics and osmotic laxative changes withdrawal due to adverse events compared with osmotic laxative (very low certainty).
1 finding from 1 review
Serious adverse events · children with chronic constipation without a physical explanation
1 finding from 1 review
Remission · people with active UC
Probiotics plus 5‐aminosalicylic acid (5‐ASA) (mesalazine) may leads to higher remission compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (low certainty).
1 finding from 1 review
Disease improvement · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Minor adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found